Browse by Audience
Skip to content
Papers of the Week
Anti-calcitonin gene-related peptide monoclonal antibodies for the treatment of vestibular migraine: A prospective observational cohort study.
Authors
Russo CV, Saccà F, Braca S, Sansone M, Miele A, Stornaiuolo A, De Simone RAbstract
Vestibular migraine is considered the most common cause of recurrent vertigo for which specific treatments are missing. Monoclonal antibodies against calcitonin gene-related peptide are effective in preventing migraine. Since CGRP is also detected in human cochlear and vestibular organs it may also play a role in vestibular physiology.